Pharmafile Logo

Big Data—a new player in the Healthcare Industry

April 2, 2015 |  

Big Data is an exciting by-product of the information technology revolution and offers new ways of understanding customers.

Our previous blog explored the rise of Big Data and its importance to the market research industry. In this blog we investigate some of the ways in which big pharma have used big data and consider the specific implications for us, the healthcare market research industry.

Big data is exciting to healthcare because the integration of data sources, combined with the tremendous volume of data now available, affords pharma the chance to gain fresh insights into patient behavior and HCP decision-making, as well as make improvements to overall health system planning.  Major pharma companies, such as Astra Zeneca and GSK, have been quick to embrace Big Data to gain additional market understanding. For example, Astra Zeneca recently partnered with a data analytics company, Healthcore, which analyses insurance claims. By combining large amounts of medical records with insurance claim data, AZ was able to establish the relationship between treatment effectiveness and cost of care. This helps the company to identify more effective and affordable treatment for patients. This level of analytics, which gives pharmaceutical companies a means of developing more effective pricing strategies, is one that traditional market research agencies are unlikely to be equipped to offer.

GSK applied Big Data analysis in order to identify target customers. By working with data analytics company Occam, GSK aimed to “identify people who are mentioning a particular brand of ours but also track everything else they are talking about in the public domain to build a customer profile”, said James Parker, GSK’s CRM consultant. In this example, Big Data could realise real-time monitoring and reporting, in a way which traditional market research agencies cannot.

Consequently, we as market researchers must face the question: With Big Data analytics on the increase, will primary market research become redundant? 

We would like to think not. There are two skills required by both researchers conducting traditional primary market research and Big Data research. The first is an in-depth knowledge of the industry. This arms researchers with the ability to design the best solution to answer the business question. Secondly, researchers require the ability to analyze the findings and provide actionable recommendations which help companies increase their profitability and sustainability.

However, there are distinct differences between the two types of research in terms of approach and analysis. One characteristic of current Big Data research is that it is largely retrospective and mainly uses existing data. Sometimes the volume of data means that it can be used as a predictor of future behaviour, but this is open to misinterpretation. Big Data analysis sometimes gives ambiguous findings because of the limited context around the business question being addressed. Overall, Big Data is useful for making sense of the big picture and identifying overall trends and patterns but sometimes it can’t be relied upon to answer business questions at a more granular level. 

Primary market research takes a more structured approach. Data collection and analysis are controlled, meaning the findings should directly answer the research objective and address the business question. It is very valuable when you want to gather in-depth insights from specific types of audiences.

So what does the future hold for the healthcare market research industry? Well we think ideally we should be working in partnership to deliver an integrated solution. Primary market research will still be required to fill the gaps in understanding which Big Data is unable to provide. And primary market research agencies, should explore the possibility of partnering with Big Data analytics agencies, or even developing in-house analytics team, in order to provide a one-stop market research service for clients.

Research Partnership is one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges. Find out more here: http://bit.ly/1F7rEiF 

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Guide

UX research

Article: Why pharma must trust the science of behaviour

In a recent interview with PME Magazine, Dan Coffin, Director explains why the application of behavioural science will be key to better health far beyond COVID-19.Read the full article here:...

Case study

Using qualitative conjoint to assess willingness-to-pay

Consumer health specialist joins Research Partnership Inc

Global healthcare market research consultancy Research Partnership has appointed Jennifer Stewart as a Director in their US offices in Philadelphia.

Article: What’s next? How behavioural science can support pharma’s future

Dan Coffin, Director explains why now is an opportune time for pharma marketers to embrace behavioural science. Read his latest article for PME Magazine.https://bit.ly/31ef6rh

Video: UX/ Experience design research

Director and UX expert Liza Pliss discusses Research Partnership's approach to user experience research and shares an example of a project where using design thinking led to an agile approach...

White paper: The impact of COVID-19 on chronic disease management

Therapy Watch, Research Partnership's syndicated PRF tracker, has been investigating the impact of COVID-19 on chronic disease management. In this white paper, Research Partnership share some of the insights and...

Article: Pricing a coronavirus vaccine

Using findings from Research Partnership's recent COVID-19 impact study, Market Access Directors Rachel Howard and Brett Gardiner and Consultant Suzan Serip explore the challenges of pricing a coronavirus vaccine. Read...

News: Living with Ulcerative Colitis and Crohn’s Disease

Living with Ulcerative Colitis (UC) and Crohn’s Disease (CD) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs. These reports...

Interactive infographic

Living With: The journey from the patient’s perspective